TNFRSF1A and cancer: Our work also represents a new concept in the design of TNFR1-targeted therapies as this is the first time that an agent has been reported to stimulate efficiently TNFR1 inhibiting cancer cell growth and concurrently eliminate the activation of NF-κB.